St. Francis Cancer Center | St. Francis Cancer Center | Available Clinical Trials
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
421
page-template,page-template-full_width_inside,page-template-full_width_inside-php,page,page-id-421,page-child,parent-pageid-283,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Available Clinical Trials

Search Clinical Trials

To view available Clinical Trials, search using the fields below. For more information about an available trial, contact our Oncology Research Department at 864-603-6211.

Available Clinical Trials

Search by Type: or
Reset

Displaying All Clinical Trials (88)
A011106
ALTernate approaches for clinical stage II or III Estrogen Receptor …
A011202
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection …
A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss …
A011502
Alliance A11502 - Aspirin in Preventing Recurrence of Cancer in Patients …
A061402
A061402 - Solitary Plasmacytoma of Bone: Randomized Phase III Trial …
A081105
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo …
A151216
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). …
Actinium API-01
A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with …
ADVL1622
ADVL1622 - Phase 2 Trial of XL184 (Cabozantinib), an Oral …
AEWS1221
AEWS1221 - Randomized Phase 3 Trial Evaluating the Addition of …
Alexion(AHUS)
An Observational , Non-Interventional, Multi-Center, Multi-National Study of Patients with …
Amgen 20150288
A Phase 2 Open-Label Study Investigating the Safety and Efficacy …
Amgen 20150292
A Phase 2/3 Multi-center Study to Evaluate the Safety and …
ARST1321
Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A …
Astex SGI-110-07
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) …
Bayer 17777
A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus …
Biodesix BDX-00146 (INSIGHT)
An Observational Study Assessing the Clinical Effectiveness of VeriStrat and …
BMS CA209-227
An Open label, Randomized Phase 3 trial of Nivolumab, or …
BMS CA209-436
A Phase I/ II Study to Evaluate the Safety and …
BMS CA209-592
An Exploratory Study of the Biologic Effects and Biomarkers of …
CALGB 30610
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with …
CALGB 50801
Response-Based Therapy Assessed By PET Scan in Treating Patients With …
Cancer Insight – Melanoma Vaccine
A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an …
CC-5013-DLC-002 (ROBUST)
Efficacy and safety study to compare Lenalidomide (CC-55013) plus R-CHOP Chemotherapy …
CerRx FEN-T14
Phase II Trial of Intravenous Fenretinide (N-(4-hydroxyphenyl) retinamide, 4-HPR) Emulsion …
E1910
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed …
E1A11
 A Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone …
E2112
A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo …
E2810
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in …
E3A06
A Randomized Phase III Trial of Lenalidomide Versus Observation Alone …
E4512
A Phase III Double-Blind Trial for Surgically Resected Early Stage …
EA1131
Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. …
EA5142
EA5142 - A Randomized Phase III Study of Nivolumab After …
EA6134
EA6134 - A Randomized Phase III Trial of Dabrafenib + …
EA8143
EA8143 – A Phase 3 RandOmized Study Comparing PERioperative Nivolumab …
EAQ 152
COMET - Communication and Education in Tumor Profiling: A Randomized …
EAY131 and link to sub-protocols
Molecular Analysis for Therapy Choice (MATCH). Read more>
Genentech W030070
A Phase III, Multicenter, Randomized, Placebo-Controlled Study of Atezolizumab (Anti-PD-L1 Antibody) …
Gilead GS-US-339-1559
A Phase 1b/2 Study of Entospletinib (GS-9973) Monotherapy and in …
GOG 0263
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation …
GRAIL-001
The Circulating Cell-Free Genome Atlas (CCGA) Study. GRAIL is using …
IMGN 529-0302
A Phase 2 Study to Evaluate the Efficacy and Tolerability …
Janssen 54767414MMY2012
Daratumumab plus Cyclophosphamide, Bortezomib and Dexamethasone (Dara-CyBorD) in Previously Untreated …
Janssen 6393593MYF2001
A randomized, single-blind, Multicenter Phase 2 Study to evaluate the …
Just In Time – 265-101
Open-Label Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics …
Just In Time – DS6051-A-U101
A Phase I, Two-Part, Multi-Center, Non-Randomized, Open Label, Multiple Dose …
Just In Time – MS200095-0022
A Phase II single-arm trial to investigate tepotinib in stage …
Just In Time Pharmatech 265-109
Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally …
Just In Time Pharmatech B3281006
A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY OF PF-05280586 VERSUS RITUXIMAB …
Just In Time Pharmatech I4T-MC-JVCY
A Multicenter, Randomized, Double-Blind Study of Erlotinibin Combination with Ramucirumab …
Just In Time Pharmatech RX-00201-P2-A-09
A Multicenter, Open-label, Phase 1b/2 Study to Evaluate the Safety …
Just In Time Pharmatech RXDX-101-02
Entrectinib For Locally Advanced or Metastatic Solid Tumors That Harbor …
Just In Time Pharmatech RXDX-105-01
AN OPEN-LABEL, PHASE 1/1B, SINGLE-AGENT STUDY OF RXDX-105 IN PATIENTS …
Merck MK-3475-177
A Phase III Study of Pembrolizumab (MK-3475) vs. Chemotherapy in …
Merck MK-3475-355
A Randomized, Double-Blind, Phase III Study of Pembrolizumab (MK-3475) Plus …
Merck MK-3475-604
A Phase III Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK- …
Methylgene 516-001
A Phase 1/1b Study of MGCD516 in Patients With Advanced …
MK-3475-170
A Phase II Study of Pembrolizumab (MK-3475) in Subjects with …
NHLBI-MDS
The National Myelodysplastic Syndromes (MDS) Study
Novartis Signature CINC280A2201
A Phase II, multicenter, four-cohort study of oral cMET inhibitor …
Novartis Signature CPDR001X2201
A phase II, open-label, randomized controlled study of PDR001 in …
NRG BR003
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin …
NRG GY003
Phase II Randomized Trial of Nivolumab with or without Ipilimumab …
NRG GY004
A Phase III Study Comparing Single-Agent Olaparib or the Combination …
NRG GY006 – Temp Closing 6/30/17
A Randomized Phase II Trial of Radiation Therapy and Cisplatin …
NRG HN001
Randomized Phase II and Phase III Studies of Individualized Treatment …
NRG-CC004
NRG-CC004 - Phase II Double Blind Dose Finding Trial of …
NRG-LU002
NRG-LU002 - Maintenance Systemic Therapy versus Consolidative Stereotactic Body Radiation …
NSABP B-51
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and …
NSABP B-55
 A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre Phase III Study …
Prolong SGHY-001 (Sanguinate)
An Open-Label Phase 1 Safety Study of SANGUINATE infusion in …
RTOG 0920
A Phase III Study of Postoperative Radiation Therapy (MRT) +/- …
RTOG 0924
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without …
SGN35-18
A Study to Evaluate Biomarkers of Sensitivity and Resistance and …
SPI-GCF-301
Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of …
SWOG 1207
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of …
SWOG 1216
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + …
SWOG 1314
A RANDOMIZED PHASE II STUDY OF CO-EXPRESSION EXTRAPOLATION (COXEN) WITH …
SWOG 1320
S1320, “A Randomized Phase II Trial of Intermittent Versus Continuous …
SWOG 1400
Phase II/III Biomarker-Driven Master Protocol for Previously Treated Squamous Cell …
SWOG 1400G
S1400G - A Phase II Study of Talazoparib (BMN 673) …
SWOG 1400I
A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus …
SWOG 1403
S1403, "A Randomized Phase II/III Trial of Afatinib Plus Cetuximab …
SWOG 1404
S1404: A Phase III Randomized Trial Comparing Physician/Patient Choice of …
SWOG 1416
Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without …
SWOG 1418
SWOG S1418 - A Randomized, Phase III Trial to Evaluate …
SWOG 1500
A Randomized, Phase II Efficacy Assessment of Multiple MET Kinase …
SWOG 1513
Randomized Phase II Study of 2nd Line FOLFIRI versus Modified …